813 related articles for article (PubMed ID: 16632620)
1. A quantitative study of IMRT delivery effects in commercial planning systems for the case of oesophagus and prostate tumours.
Seco J; Clark CH; Evans PM; Webb S
Br J Radiol; 2006 May; 79(941):401-8. PubMed ID: 16632620
[TBL] [Abstract][Full Text] [Related]
2. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
3. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.
Yoo S; Wu QJ; Lee WR; Yin FF
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):935-42. PubMed ID: 20044214
[TBL] [Abstract][Full Text] [Related]
5. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
6. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate.
Burman C; Chui CS; Kutcher G; Leibel S; Zelefsky M; LoSasso T; Spirou S; Wu Q; Yang J; Stein J; Mohan R; Fuks Z; Ling CC
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):863-73. PubMed ID: 9369136
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.
Chera BS; Vargas C; Morris CG; Louis D; Flampouri S; Yeung D; Duvvuri S; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):994-1002. PubMed ID: 19619961
[TBL] [Abstract][Full Text] [Related]
8. Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?
Guckenberger M; Baier K; Richter A; Vordermark D; Flentje M
Radiat Oncol; 2008 Jan; 3():3. PubMed ID: 18190681
[TBL] [Abstract][Full Text] [Related]
9. IMRT to escalate the dose to the prostate while treating the pelvic nodes.
Cavey ML; Bayouth JE; Colman M; Endres EJ; Sanguineti G
Strahlenther Onkol; 2005 Jul; 181(7):431-41. PubMed ID: 15995836
[TBL] [Abstract][Full Text] [Related]
10. Development of a simultaneous boost IMRT class solution for a hypofractionated prostate cancer protocol.
Mott JH; Livsey JE; Logue JP
Br J Radiol; 2004 May; 77(917):377-86. PubMed ID: 15121701
[TBL] [Abstract][Full Text] [Related]
11. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
14. Practical aspects of inverse-planned intensity-modulated radiation therapy for prostate cancer: a radiation treatment planner's perspective.
Parker W; Patrocinio H
Can J Urol; 2005 Jun; 12 Suppl 2():48-52. PubMed ID: 16018834
[TBL] [Abstract][Full Text] [Related]
15. Effect of MLC leaf width on treatment adaptation and accuracy for concurrent irradiation of prostate and pelvic lymph nodes.
Shang Q; Qi P; Ferjani S; Xia P
Med Phys; 2013 Jun; 40(6):061701. PubMed ID: 23718580
[TBL] [Abstract][Full Text] [Related]
16. Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer.
Hysing LB; Skorpen TN; Alber M; Fjellsbø LB; Helle SI; Muren LP
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1496-503. PubMed ID: 18538493
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of intensity modulation inverse planning modules of three commercial treatment planning systems applied to head and neck tumour model.
Fogliata A; Bolsi A; Cozzi L
Radiother Oncol; 2003 Jan; 66(1):29-40. PubMed ID: 12559518
[TBL] [Abstract][Full Text] [Related]
18. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric advantage and clinical implication of a micro-multileaf collimator in the treatment of prostate with intensity-modulated radiotherapy.
Wang L; Hoban P; Paskalev K; Yang J; Li J; Chen L; Xiong W; Ma CC
Med Dosim; 2005; 30(2):97-103. PubMed ID: 15922176
[TBL] [Abstract][Full Text] [Related]
20. Similarities between static and rotational intensity-modulated plans.
Wu QJ; Yin FF; McMahon R; Zhu X; Das SK
Phys Med Biol; 2010 Jan; 55(1):33-43. PubMed ID: 19949257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]